Hi. I thought some of you might be interested in this.
Seems that if we do happen to get some good news or approvals, at the same time that reinvestment in biotech begins again, later this year could be a sweet spot for Meso in so many ways.
My own opinion is that a lot of investment choices will be determined by how long the Ukraine crisis continues. If that crisis ends, a lot of money will flow out of energy and have to go somewhere. And remember that covid/ long covid is not over yet.
https://endpts.com/sp/biotech-outlook-2022-ample-opportunity-for-a-rebound/
Kind regards to my friends,,,Royalsandman
Cell Therapy News/Articles, page-13389
-
- There are more pages in this discussion • 4,622 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |